Advertisement
Pardaphash Ads
  1. Home
  2. Region
  3. Uttarakhand Suspends Licences for 14 Patanjali Products Amid Misleading Advertisements Case

Uttarakhand Suspends Licences for 14 Patanjali Products Amid Misleading Advertisements Case

The licensing authority in Uttarakhand has taken action against Patanjali's Divya Pharmacy, suspending licenses for 14 of its products. The suspended products include Drishti Eye drop, Madhugrit, and Swasari Gold among others. The Uttarakhand licensing authority made the announcement, stating immediate effect.

By: Rekha Joshi  Pardaphash Group
Updated:
gnews
Uttarakhand Suspends Licences for 14 Patanjali Products Amid Misleading Advertisements Case

The licensing authority in Uttarakhand has taken action against Patanjali’s Divya Pharmacy, suspending licenses for 14 of its products. This decision, detailed in an affidavit submitted to the Supreme Court, stems from concerns over misleading advertisements.

Uttarakhand Suspends Licences for Patanjali Products


The suspended products include Drishti Eye drop, Madhugrit, and Swasari Gold among others. The Uttarakhand licensing authority made the announcement, stating immediate effect.

Suspends Licences for Patanjali Products Amid Misleading Advertisements Case


Suspends Licences for Patanjali Products Amid Misleading Advertisements Case. This move comes as part of the ongoing legal proceedings related to misleading advertisements. The Supreme Court is scheduled to hear the case, which involves an apology published by Yoga guru Ramdev and his associate Acharya Balkrishna, on April 30. Both are expected to appear in court on Tuesday.

Previously, the Supreme Court had reprimanded Patanjali for not prominently displaying their apology in newspapers. Patanjali responded by publishing a larger apology in newspapers, emphasizing their respect for the court and commitment to rectifying mistakes.

Earlier, Ramdev and Balkrishna had offered an “unconditional and unqualified apology” to the court regarding advertisements promoting products like Coronil during the pandemic. The court had directed Patanjali to cease advertisements that claimed to treat ailments, in response to a plea from the Indian Medical Association.

Further reading:
For the latest news and reviews, follow us on Google, Facebook, YouTube and X (Twitter)